author-photo

Juan Luis Ruiz-Peña

24

Papers

302

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Real world data on the use of ocrelizumab. Incidence of lymphopenia, B-cell and immunoglobulins evolution

2021 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (0)
Skin Autoimmunity Secondary to Alemtuzumab in a Tertiary Care Spanish Hospital

2021
Show All
- Source
- Cite
- Save
Citations (0)
Rebound after discontinuation of teriflunomide in patients with multiple sclerosis: 2 case reports

2020 Multiple sclerosis and related disorders
Show All
- Source
- Cite
- Save
Citations (0)
Altered individual behavioral and EEG parameters are related to the EDSS score in relapsing-remitting multiple sclerosis patients

2019 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (6)
Pancreatitis aguda en pacientes tratados con teriflunomida

2019 Neurología Argentina
Show All
- Source
- Cite
- Save
Citations (0)
Vitiligo con fenomeno de Koebner en una paciente con esclerosis multiple tratada con alemtuzumab.

2018 Revista De Neurologia
Show All
- Source
- Cite
- Save
Citations (2)
Retest reliability of individual alpha ERD topography assessed by human electroencephalography

2017 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (9)
Short-term suboptimal response criteria for predicting long-term non-response to first-line disease modifying therapies in multiple sclerosis: A systematic review and meta-analysis

2016 Journal of the Neurological Sciences
- Jordi Río
- Juan Luis Ruiz-Peña
Show All
- Source
- Cite
- Save
Citations (15)
A new risk variant for multiple sclerosis at the immunoglobulin heavy chain locus associates with intrathecal IgG, IgM index and oligoclonal bands

2015 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (9)
Neural Correlates of Alerting and Orienting Impairment in Multiple Sclerosis Patients

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (26)